A new study suggests that the shingles vaccine, known for preventing the painful viral infection, may also slow the progression of dementia . Shingles, caused by the varicella-zoster virus, affects about one in three people in the United States during their lifetime. The risk of shingles and its complications increases with age, leading to the recommendation of a two-dose vaccine for adults aged 50 and older.

The study, published in the journal Cell , indicates that the shingles vaccine could have therapeutic properties against dementia. Dr. Pascal Geldsetzer , an assistant professor of medicine at Stanford University and the study's senior author, explained that the vaccine might reduce the risk of dying from dementia . "We see an effect on your probability of dying from dementia

See Full Page